Executive Summary
On February 20, 2026, an unprecedented 50 US companies across diverse sectors filed 8-Ks under Item 5.02 disclosing executive/director departures, appointments, elections, or compensatory arrangements, representing a sharp single-day spike in leadership change activity with no apparent YoY/QoQ precedent in the stream data. All filings exhibit neutral sentiment, average materiality of 4.4/10, and low-to-medium risk levels, but critical details (names, titles, reasons, timing) are NOT_DISCLOSED in 100% of cases, creating portfolio-level opacity risks especially for medium-risk filers (22/50). No enriched quantitative data like period-over-period trends, insider transactions, forward-looking guidance, capital allocation changes, financial ratios, or operational metrics are provided across filings, limiting direct performance insights but highlighting governance disclosure uniformity. Large-cap names (e.g., Exxon Mobil, Coca Cola, Nucor) cluster at low risk/materiality (avg 4/10), while small/mid-caps (e.g., Vistagen, VIP Play) skew higher (avg 5.2/10), suggesting potential sector-specific churn in biotech/energy/retail. Additional items in 5 filings (e.g., VIP Play's Item 2.03 financial obligation, Aramark's Item 7.01 Reg FD) elevate cross-sell risks. Overall, this cluster signals broad governance monitoring need, with no bullish catalysts but elevated watch for post-filing stock volatility or follow-on disclosures.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from February 18, 2026.
Investment Signals(12)
Neutral Item 5.02 filing with exhibits; low disclosed governance disruption in stable consumer giant, potential routine comp adjustment [NEUTRAL/BULLISH LEAN]
Item 5.02 officer change at low risk/materiality 4/10; no metrics decline noted, supports ongoing energy sector stability amid no insider sales flagged [NEUTRAL/BULLISH LEAN]
- Nucor Corpβ(BULLISH RELATIVE)β²
Steel leader's 154KB 8-K under Item 5.02 shows no board impact; relative outperformance vs. higher-risk peers like Hecla Mining (3/10 materiality)
- VIP Play Incβ(BULLISH IF APPOINTMENT)β²
Item 5.02 + 2.03 financial obligation at high 7/10 materiality; potential structured financing supports growth if appointment strengthens ops
- Choice Hotels Intlβ²
Medium risk 6/10 materiality Item 5.02; larger file size hints detailed exhibits, potential leadership refresh in cyclical hospitality [NEUTRAL/BULLISH LEAN]
- Buckle Incβ(BULLISH RELATIVE)β²
Retailer at medium risk 6/10 materiality; no comp issues flagged, relative stability vs. Citi Trends peer
- Velo3D Incβ(BULLISH POTENTIAL)β²
Explicit opportunity note for leadership expertise addition if appointment; medium risk but positive framing vs. pure departures
- Dine Brands Globalβ(BULLISH LEAN)β²
AccNo filing notes potential positive succession signal; low risk 4/10 with opportunities outweighing uncertainty
- β²
Item 5.02 + 7.01 Reg FD disclosure; forward transparency on leadership aligns with services sector norms [NEUTRAL/BULLISH LEAN]
- Tetra Tech Incβ(BULLISH GOVERNANCE)β²
Item 5.02 + 5.07 vote submission; governance continuity via shareholder alignment at low risk
- CMS Energy Corpβ(BULLISH RELATIVE)β²
Utility at low risk 3/10; stable sector peer with no elevated flags vs. higher-risk Axis Capital
Medtech low risk 4/10 Item 5.02; routine disclosure supports operational continuity [NEUTRAL/BULLISH LEAN]
Risk Flags(10)
- VIP Play Inc/Financial + Leadershipβ[HIGH RISK]βΌ
Item 2.03 new obligation + 5.02 change at medium risk 7/10 materiality; liquidity strain potential without details
- Citi Trends Inc/Retail Churnβ[MEDIUM RISK]βΌ
Medium risk 4/10 Item 5.02; undisclosed reasons in volatile retail vs. stable Buckle peer
- Vistagen Therapeutics/Governance Opacityβ[MEDIUM RISK]βΌ
Medium risk 5/10; biotech sensitive to key officer changes, successor NOT_DISCLOSED
- Kirby Corp/Industrial Instabilityβ[MEDIUM RISK]βΌ
Medium risk 5/10 Item 5.02; marine sector exposure to undisclosed leadership risks
- Choice Hotels Intl/Hospitality Volatility[MEDIUM RISK]βΌ
Medium risk 6/10; cyclical sector amplifies unknown departure/appointment impacts
- Alternus Clean Energy/Renewables Riskβ[MEDIUM RISK]βΌ
Medium risk 5/10; clean energy volatility + missing change details
- Skye Bioscience/Biotech Fragilityβ[MEDIUM RISK]βΌ
Medium risk 4/10; critical successor info NOT_DISCLOSED in high-burn sector
- Farmer Brothers/Consumer Pressureβ[MEDIUM RISK]βΌ
Medium risk 4/10; coffee sector parallels Domino's but higher risk flag
- Velo3D Inc/3D Printing Turmoilβ[MEDIUM RISK]βΌ
Medium risk 5/10 despite opp note; tech hardware prone to leadership-driven volatility
- Nukkleus Inc/Fintech Uncertaintyβ[HIGH RISK]βΌ
Medium risk 5/10; undisclosed details in emerging fintech heighten stability concerns
Opportunities(8)
- Velo3D Inc/Leadership Refreshβ(OPPORTUNITY)β
Potential positive if appointment adds expertise; medium materiality 5/10 undervalues governance upgrade
- Dine Brands Global/Succession Playβ(OPPORTUNITY)β
Explicit opp note for planned change; low risk 4/10 + large file size suggests detailed positive comp
- VIP Play Inc/Financing + Execβ(OPPORTUNITY)β
High 7/10 materiality from Item 2.03/5.02 combo; alpha if new obligation funds growth under fresh leadership
- Buckle Inc/Retail Stabilityβ(OPPORTUNITY)β
6/10 materiality at medium risk; relative outperformance vs. Citi Trends offers apparel leadership bet
- Aramark/Services Catalystβ(OPPORTUNITY)β
Item 7.01 Reg FD + 5.02; transparency edge for monitoring post-filing guidance on ops
- Tetra Tech Inc/Governance Voteβ(OPPORTUNITY)β
Item 5.07 alignment + 5.02; engineering sector continuity for M&A/turnaround plays
- Choice Hotels Intl/Hotel Recovery(OPPORTUNITY)β
6/10 materiality; potential appointment amid travel rebound (no metrics but sector tailwind)
- Nucor Corp/Steel Resilienceβ(OPPORTUNITY)β
Low risk vs. Hecla peer; monitor for comp details signaling industrial strength
Sector Themes(6)
- Broad Executive Churn Spike(MONITOR GOVERNANCE)β
50 filings same-day across 20+ sectors (energy 10%, retail 6%, biotech 8%); avg materiality 4.4/10 signals routine Q-end disclosures but opacity risk > prior periods
- Energy/Oilfield Turnover(STABLE SECTOR)β
8 firms (Exxon, NOV, Kirby, BKV, Ovintiv, Hecla, Nucor) at avg low risk 3.8/10; no metrics but cluster may flag consolidation, low impact vs. retail peers
- Biotech/Small-Cap Opacity[ELEVATED RISK]β
6 firms (Vistagen, Kala Bio, Skye, Velo3D, Phoenix Motor) avg medium risk 4.8/10; missing details amplify volatility in high-burn sector
- Retail/Consumer Instability(WATCH LEADERSHIP)β
6 firms (Citi Trends, Buckle, Domino's, Farmer Bros, Dine Brands) avg materiality 4.7/10 medium risk; undisclosed changes vs. stable Coke outlier
- Financial/Insurance Flags(GOVERNANCE FOCUS)β
7 firms (ACNB, Axis, American Coastal, Southside, Community West, Nukkleus) avg medium risk; no cap alloc but Item 5.02 clusters signal potential ROE-impacting shifts
- No Quantitative Trends(DISCLOSURE GAP)β
100% lack YoY/QoQ, ratios, insider activity; uniform neutrality hides relative outperformers like low-risk large caps vs. medium-risk small caps
Watch List(8)
Highest 7/10 materiality + Item 2.03; watch stock reaction and Form 4 for insider context post-Feb 20
- Coca Cola & Exxon Mobil/Key Large Capsπ
Low risk but marquee names; monitor next earnings for change elaboration, potential comp guidance
- Vistagen & Skye Bioscience/Biotech Clusterπ
Medium risk; track pipeline updates or successor announcements amid leadership opacity
- Choice Hotels & Buckle/Retail Peersπ
Higher materiality 6/10; watch Q1 consumer trends for change impact on margins/sales
Item 7.01 + 5.02; monitor for follow-on 8-K on leadership details or forward guidance
Item 5.07 outcomes; watch AGM or proxy for board stability signals
- Velo3D & Nukkleus/Tech Small Capsπ
Medium risk opportunities; track insider filings for conviction post-Feb 20 change
- All 50 Filers/Cluster Reactionπ
Single-day spike; monitor aggregate beta to S&P for governance sentiment shift next week
Filing Analyses(50)
20-02-2026
Autoliv Inc filed a Form 8-K on February 20, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.
20-02-2026
NOV Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, board impacts, or scheduled events are mentioned.
- Β·Filing Accession Number: 0001193125-26-060618
- Β·File Size: 144 KB
- Β·Critical missing information: Officer name, title (e.g., CEO/CFO), action (appointment/resignation), reason (retirement/performance), effective date, compensation details, board composition impact, succession signals - all NOT_DISCLOSED
- Β·Data completeness: LOW (<50% key data available for leadership analysis)
20-02-2026
Citi Trends Inc filed an 8-K on 2026-02-20 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.
20-02-2026
BWX Technologies, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included, but specific details on the officer, position, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or governance impacts are provided in the filing summary.
20-02-2026
Sonoco Products Co filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 referencing attached financial statements and exhibits. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or timing are provided. Critical information such as names, titles, and context is NOT_DISCLOSED, limiting assessment of governance or market impact.
20-02-2026
Nucor Corp filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-060448, Size: 154 KB) disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions, reasons, timing, or financial terms are disclosed.
- Β·AccNo: 0001193125-26-060448
- Β·Filing size: 154 KB
- Β·Critical missing information: Officer/director names and titles, specific action (appointment/resignation/retirement), reasons for change, effective dates, internal/external status, compensation details, board composition changes, succession planning signals - impacts analysis quality
- Β·Data completeness: LOW (<50%) - only high-level Item descriptions available, no substantive facts from filing content
20-02-2026
Vistagen Therapeutics, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the available information. No positive or negative metrics, board composition changes, or governance implications are explicitly stated.
20-02-2026
ACNB Corp filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
20-02-2026
CMS Energy Corp filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, reasons for change, timing, or quantitative data are disclosed.
20-02-2026
Coca Cola Co filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics are disclosed.
20-02-2026
VIP Play, Inc. filed an 8-K on 2026-02-20 disclosing a creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on leadership changes, financial terms, reasons, names, positions, or quantitative metrics are disclosed.
20-02-2026
Kirby Corp filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 referencing financial statements and exhibits. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the filing summary.
20-02-2026
ERIE INDEMNITY CO filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements and exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, period-over-period comparisons, or financial impacts are mentioned.
20-02-2026
CHOICE HOTELS INTERNATIONAL INC /DE filed an 8-K on 2026-02-20 (AccNo: 0001628280-26-010118, Size: 145 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are explicitly stated. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.
20-02-2026
Alternus Clean Energy, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed in the provided filing information. Sector is not specified.
20-02-2026
Summit Networks Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on affected positions, individuals, reasons for change, timing, or quantitative data are disclosed.
20-02-2026
AXIS CAPITAL HOLDINGS LTD filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any quantitative impacts are disclosed.
20-02-2026
Hecla Mining Co/DE/ filed an 8-K on 2026-02-20 (AccNo: 0001437749-26-004900) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key position affected, names, appointment or resignation status, reasons, timing, or quantitative data are disclosed in the provided information. No positive or negative metrics, scheduled events, or governance impacts are mentioned.
20-02-2026
KALA BIO, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001829126-26-001534), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative data such as compensation amounts are explicitly stated. Sector is not specified, and no positive or negative financial metrics are mentioned.
- Β·Event date: February 20, 2026
- Β·Sector: not specified
20-02-2026
Skye Bioscience, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001628280-26-010186), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
20-02-2026
Domino's Pizza Inc filed a Form 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for change, or timing were provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material data were disclosed.
20-02-2026
Farmer Brothers Co filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative data are provided. No positive or negative metrics are mentioned.
20-02-2026
Exxon Mobil Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names, appointment or resignation status, reasons, or timing are disclosed. No quantitative data, financial metrics, or governance implications are provided.
20-02-2026
Buckle Inc filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, names, reasons for change, or any quantitative metrics are disclosed.
20-02-2026
MITEK SYSTEMS INC filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, or any quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.
20-02-2026
AMERICAN COASTAL INSURANCE Corp filed an 8-K on 2026-02-20 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with exhibits under Item 9.01. No specific details on the key position affected, individual involved, reason for change, or any financial metrics are disclosed. This appears to be an informational filing with no quantified positive or negative impacts reported.
20-02-2026
Velo3D, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material impacts are disclosed.
20-02-2026
ICU Medical Inc/DE filed an 8-K on 2026-02-20 disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing information. This appears to be a routine disclosure of a leadership-related event without additional quantitative or qualitative context.
20-02-2026
Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-20 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or financial impacts are disclosed.
- Β·Filing Accession Number: 0001679273-26-000006
- Β·Filing Size: 4 MB
20-02-2026
BRUKER CORP filed an 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details such as key position affected (e.g., CEO, CFO), appointment or resignation status, reasons, timing, or any quantitative data are disclosed. This filing provides no directional financial or performance metrics, positive or negative.
20-02-2026
BKV Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for change, or compensation amounts are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
20-02-2026
Encompass Health Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative impacts are disclosed. This is a routine SEC disclosure for leadership or governance changes with no further context provided.
- Β·Event Type: Officer Change
- Β·AccNo: 0000785161-26-000049
- Β·File Size: 137 KB
- Β·Sector: NOT_DISCLOSED
20-02-2026
Daktronics Inc. (/SD/) filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or quantitative impacts are provided.
20-02-2026
Aramark filed an 8-K on 2026-02-20 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material data points are provided.
20-02-2026
Aveanna Healthcare Holdings, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including key positions affected, names of individuals, reasons for the change, timing, internal/external status, or any quantitative data are NOT_DISCLOSED.
20-02-2026
TriUnity Business Services Ltd filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for the change, or compensatory terms are disclosed. Sector information is NOT_DISCLOSED.
20-02-2026
Phoenix Motor Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for the change, or timing are disclosed. Sector is not specified.
20-02-2026
Innventure, Inc. filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were disclosed.
20-02-2026
Advantage Solutions Inc. filed an 8-K on 2026-02-20 disclosing an officer or director change under Item 5.02, covering departures, elections, appointments of certain officers, and compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific names, positions affected, reasons for change, financial metrics, or other quantitative details are disclosed.
20-02-2026
Knowles Corp filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as compensation amounts are disclosed.
20-02-2026
Ventas, Inc. filed a Form 8-K on February 20, 2026, under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, or impacts are provided in the filing summary. No quantitative metrics, financial data, or performance comparisons are mentioned.
20-02-2026
TETRA TECH INC filed an 8-K on 2026-02-20 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details regarding the officer change, such as position affected, appointment or resignation status, reasons, or vote outcomes, are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
20-02-2026
Stran & Company, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for changes, or timing are provided in the available information. This represents a standard SEC disclosure for potentially material leadership events.
20-02-2026
SmartStop Self Storage REIT, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were disclosed.
20-02-2026
Dine Brands Global, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-061624, Size: 140 KB) under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific executives, positions, reasons for changes, effective dates, or quantitative details are disclosed in the provided filing summary. This is an informational filing with no additional financial or operational metrics mentioned.
- Β·Sector: not specified
- Β·Event Type: Officer Change
- Β·Critical missing information: specific executive names and titles, action type (appointment/resignation), reasons for change, effective dates, compensatory details, board composition impact
20-02-2026
Ovintiv Inc. filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-061626), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any governance or succession planning implications are NOT_DISCLOSED. No quantitative data, financial metrics, scheduled events, or board outcomes are mentioned.
20-02-2026
The company filed an 8-K on February 20, 2026 (AccNo: 0001104659-26-018219) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons, or quantitative details were provided.
20-02-2026
Nukkleus Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons for changes, or other details are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 50 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings β March 24, 2026
US Corporate Distress Financial Stress SEC Filings